147 results
Page 4 of 8
10-K
EX-10.63
andjsz4w9 4rrei
12 Feb 18
Annual report
12:00am
10-K
lold38bw1ob9ebr0
12 Feb 18
Annual report
12:00am
10-K
EX-10.32
9u55z1t7 c3z8mt
12 Feb 18
Annual report
12:00am
10-K
EX-10.20
tl81clj
12 Feb 18
Annual report
12:00am
10-K
EX-10.59
b5l0rxcrn1m9n yh6
12 Feb 18
Annual report
12:00am
10-K
EX-10.21
t9650yyv
12 Feb 18
Annual report
12:00am
10-K
EX-10.31
qyrho73 xt
12 Feb 18
Annual report
12:00am
10-K
EX-10.52
7kbtl1nr
12 Feb 18
Annual report
12:00am
10-K
EX-10.23
pox xs7ndsw8
12 Feb 18
Annual report
12:00am
10-K
EX-10.39
g0euwyo7hxpijeui1yu
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
wiot7fdf
12 Feb 18
Annual report
12:00am
10-K
EX-10.56
982q9t1 c58ki6k
12 Feb 18
Annual report
12:00am
10-K
EX-10.61
eyy5h
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
gsr2ze qkc6496g
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
424B5
pkuugcn46pz9w5
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
1syk bi7k2k4zt2lhzk
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
ioosthake5e5 uxm3o
30 Nov 15
Current report (foreign)
12:00am